Company: LASE
Filing Date: 2025-10-21
Form Type: S-1/A
Source: 0001493152-25-018753
Chunk: 3

Company: Laser Photonics Corp
Filing Date: 2025-10-21
Form: S-1/A
Chunk 3
---
 or other successors-in-interest, will sell the Shares through public or private transactions at prevailing market prices, at prices related to prevailing market prices or at privately negotiated prices. The Selling Stockholders may sell any, all or none of the Shares offered by this prospectus, and we do not know when or in what amount the Selling Stockholders may sell their Shares hereunder following the effective date of this registration statement. We provide more information about how a Selling Stockholder may sell its Shares in the section titled “Plan of Distribution” on page 15.

We are registering the Shares on behalf of the Selling Stockholders, to be offered and sold by them from time to time. While we will not receive any proceeds from the sale of the Shares by the Selling Shareholders, we may receive cash proceeds equal to the total exercise price of the Common Warrants and the Hudson Warrant to the extent that the Common Warrants or Hudson Warrant are exercised for cash. However, we cannot predict when and in what amounts or if the Common Warrants or Hudson Warrant will be exercised for cash, and it is possible that the Common Warrants and Hudson Warrant may expire and never be exercised or be exercised, if at all, only on a cashless basis, in which each case we would not receive any cash proceeds. We have agreed to bear all of the expenses incurred in connection with the registration of the Shares. The Selling Stockholders will pay or assume discounts, commissions, fees of underwriters, selling brokers or dealer managers and similar expenses, if any, incurred for the sale of the Shares.

The Common Warrants offered hereby will have an exercise price of $3.40 per share and will be exercisable upon issuance (the “Initial Exercise Date”). The Series A warrants and the Placement Agent Warrants will expire five (5) years from the Initial Exercise Date and the Series B warrants will expire eighteen (18) months from the Initial Exercise Date. The exercise price and number of shares of our Common Stock issuable under the Common Warrants and Placement Agent Warrants are subject to adjustment as described in the Common Warrants and Placement Agent Warrants. This prospectus also relates to the offering of our Common Stock issuable upon exercise of the Common Warrants and Placement Agent Warrants.

Our common stock trades on the Nasdaq Capital Market (“Nasdaq”) under the symbol “LASE”. On October 20, 2025, the last reported sales price of our common stock was $4.01 per share.

We are an “em